최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Bioinformatics, v.36 no.10, 2020년, pp.3049 - 3055
Ryu, Jae Yong (Information-based Drug Research Center , Korea Research Institute of Chemical Technology, 34114 Daejeon, Republic of Korea) , Lee, Mi Young (Information-based Drug Research Center , Korea Research Institute of Chemical Technology, 34114 Daejeon, Republic of Korea) , Lee, Jeong Hyun (Information-based Drug Research Center , Korea Research Institute of Chemical Technology, 34114 Daejeon, Republic of Korea) , Lee, Byung Ho (Information-based Drug Research Center , Korea Research Institute of Chemical Technology, 34114 Daejeon, Republic of Korea) , Oh, Kwang-Seok (Information-based Drug Research Center , Korea Research Institute of Chemical Technology, 34114 Daejeon, Republic of Korea)
AbstractMotivationBlockade of the human ether-à-go-go-related gene (hERG) channel by small compounds causes a prolonged QT interval that can lead to severe cardiotoxicity and is a major cause of the many failures in drug development. Thus, evaluating the hERG-blocking activity of small compou...
Br. J. Pharmacol Behm 161 207 2010 10.1111/j.1476-5381.2010.00889.x GSK1562590, a slowly dissociating urotensin-II receptor antagonist, exhibits prolonged pharmacodynamic activity ex vivo
Mol. Inform Braga 34 698 2015 10.1002/minf.201500040 Pred-hERG: a novel web-accessible computational tool for predicting cardiac toxicity
J. Chem. Inf. Model Cai 59 1073 2019 10.1021/acs.jcim.8b00769 Deep learning-based prediction of drug-induced cardiotoxicity
J. Med. Chem Cavalli 45 3844 2002 10.1021/jm0208875 Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers
Nature Chong 448 645 2007 10.1038/448645a New uses for old drugs
J. Clin. Pharmacol Darpo 46 498 2006 10.1177/0091270006286436 Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 guideline
J. Comput. Aided Mol. Des Didziapetris 30 1175 2016 10.1007/s10822-016-9986-0 Compilation and physicochemical classification analysis of a diverse hERG inhibition database
ChemMedChem Doddareddy 5 716 2010 10.1002/cmdc.201000024 Prospective validation of a comprehensive in silico hERG model and its applications to commercial compound and drug databases
J. Cheminform Dong 10 16 2018 10.1186/s13321-018-0270-2 PyBioMed: a python library for various molecular representations of chemicals, proteins and DNAs and their interactions
J. Pharmacol. Exp. Ther Ekins 301 427 2002 10.1124/jpet.301.2.427 Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel
J. Cheminform Ertl 1 8 2009 10.1186/1758-2946-1-8 Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions
Nucleic Acids Res Gaulton 40 D1100 2012 10.1093/nar/gkr777 ChEMBL: a large-scale bioactivity database for drug discovery
Nucleic Acids Res Gilson 44 D1045 2016 10.1093/nar/gkv1072 BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology
Nature LeCun 521 436 2015 10.1038/nature14539 Deep learning
Int. Immunopharmacol Lee 40 196 2016 10.1016/j.intimp.2016.09.002 A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension
BMC Bioinformatics Lee 20 250 2019 10.1186/s12859-019-2814-5 Computational determination of hERG-related cardiotoxicity of drug candidates
Mol. Inform Li 36 1700074 2017 10.1002/minf.201700074 Modeling of the hERG K+ channel blockage using online chemical database and modeling environment (OCHEM
J. Cheminform Moriwaki 10 4 2018 10.1186/s13321-018-0258-y Mordred: a molecular descriptor calculator
Front. Pharmacol Munawar 9 1035 2018 10.3389/fphar.2018.01035 Experimentally validated pharmacoinformatics approach to predict hERG inhibition potential of new chemical entities
In: Proceedings of the 27th International Conferenceon Machine Learning (ICML-10), Haifa, Israel, pp. 807-814. Nair 2010 Rectified linear units improve restricted Boltzmann machines
Eur. J. Pharmacol Oh 799 94 2017 10.1016/j.ejphar.2017.02.003 A novel urotensin II receptor antagonist, KR-36996, improved cardiac function and attenuated cardiac hypertrophy in experimental heart failure
Toxicol. Lett Park 216 9 2013 10.1016/j.toxlet.2012.10.018 Predicted drug-induced bradycardia related cardio toxicity using a zebrafish in vivo model is highly correlated with results from in vitro tests
J. Mach. Learn. Res Pedregosa 12 2825 2011 Scikit-learn: machine learning in python
Pereira 2960 2012
Channels (Austin) Priest 2 87 2008 10.4161/chan.2.2.6004 Role of hERG potassium channel assays in drug development
Cardiovasc. Res Redfern 58 32 2003 10.1016/S0008-6363(02)00846-5 Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
J. Chem. Inf. Model Rogers 50 742 2010 10.1021/ci100050t Extended-connectivity fingerprints
Ryu 2018
Cell Sanguinetti 81 299 1995 10.1016/0092-8674(95)90340-2 A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel
Bioorg. Med. Chem Thai 16 4107 2008 10.1016/j.bmc.2008.01.017 A binary QSAR model for classification of hERG potassium channel blockers
Adv. Drug Deliv. Rev Villoutreix 86 72 2015 10.1016/j.addr.2015.03.003 Computational investigations of hERG channel blockers: new insights and current predictive models
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.